New hope for rare hormone disorder: atumelnant trial launches

NCT ID NCT07144163

Recruiting now Disease control Sponsor: Crinetics Pharmaceuticals Inc. Source: ClinicalTrials.gov ↗

First seen Oct 31, 2025 · Last updated May 16, 2026 · Updated 31 times

Summary

This study tests an experimental drug called atumelnant in 150 adults with classic congenital adrenal hyperplasia (CAH), a genetic condition that disrupts hormone production. Participants will receive either atumelnant or a placebo to see if the drug can better control hormone levels and reduce the need for high-dose steroids. The goal is to improve daily management of the condition.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Crinetics Study Site
RECRUITING

Atlanta, Georgia, 30322, United States
Crinetics Study Site
RECRUITING

Chicago, Illinois, 60611, United States
Crinetics Study Site
RECRUITING

Ann Arbor, Michigan, 48109, United States
Crinetics Study Site
RECRUITING

Rochester, Minnesota, 55905, United States
Crinetics Study Site
RECRUITING

Pittsburgh, Pennsylvania, 15213, United States
Crinetics Study Site
RECRUITING

Dallas, Texas, 75390, United States
Crinetics Study Site
RECRUITING

Buenos Aires, Buenos Aires F.D., 1405, Argentina
Crinetics Study Site
RECRUITING

Buenos Aires, Buenos Aires F.D., C1012AAR, Argentina
Crinetics Study Site
RECRUITING

CABA, Buenos Aires F.D., C1199ABB, Argentina
Crinetics Study Site
RECRUITING

Córdoba, Córdoba Province, X5000JRD, Argentina
Crinetics Study Site
RECRUITING

Herston, Queensland, 4029, Australia
Crinetics Study Site
RECRUITING

Woolloongabba, Queensland, 4102, Australia
Crinetics Study Site
RECRUITING

Adelaide, South Australia, 5000, Australia
Crinetics Study Site
RECRUITING

Parkville, Victoria, 3050, Australia
Crinetics Study Site
RECRUITING

Nedlands, Western Australia, 6009, Australia
Crinetics Study Site
RECRUITING

Vienna, 1090, Austria
Crinetics Study Site
RECRUITING

Curitiba, Paraná, 33172, Brazil
Crinetics Study Site
RECRUITING

Rio de Janeiro, Rio de Janeiro, 20551-030, Brazil
Crinetics Study Site
RECRUITING

Botucatu, São Paulo, 18618-686, Brazil
Crinetics Study Site
RECRUITING

São Paulo, São Paulo, 04024-002, Brazil
Crinetics Study Site
RECRUITING

São Paulo, São Paulo, 05403-000, Brazil
Crinetics Study Site
RECRUITING

Angers, 49933, France
Crinetics Study Site
RECRUITING

Bron, 69500, France
Crinetics Study Site
RECRUITING

Nantes, 44093 Cedex 1, France
Crinetics Study Site
RECRUITING

Paris, 75013, France
Crinetics Study Site
RECRUITING

Pessac, 33604, France
Crinetics Study Site
RECRUITING

Vandœuvre-lès-Nancy, 54500, France
Crinetics Study Site
RECRUITING

Munich, Bavaria, 80336, Germany
Crinetics Study Site
RECRUITING

Würzburg, 97080, Germany
Crinetics Study Site
RECRUITING

Milan, Milano, 20149, Italy
Crinetics Study Site
RECRUITING

Padova, Padova, 35128, Italy
Crinetics Study Site
RECRUITING

Palermo, Palermo, 90127, Italy
Crinetics Study Site
RECRUITING

Naples, 80131, Italy
Crinetics Study Site
RECRUITING

Roma, 00161, Italy
Crinetics Study Site
RECRUITING

Warsaw, Masovian Voivodeship, 00-189, Poland
Crinetics Study Site
RECRUITING

London, NW1 2PG, United Kingdom

Conditions

Explore the condition pages connected to this study.

CLASSIC CONGENITAL ADRENAL HYPERPLASIA CLASSIC CONGENITAL ADRENAL HYPERPLASIA CONGENITAL ADRENAL HYPERPLASIA